Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9725109rdf:typepubmed:Citationlld:pubmed
pubmed-article:9725109lifeskim:mentionsumls-concept:C0026549lld:lifeskim
pubmed-article:9725109lifeskim:mentionsumls-concept:C0002658lld:lifeskim
pubmed-article:9725109lifeskim:mentionsumls-concept:C0024501lld:lifeskim
pubmed-article:9725109lifeskim:mentionsumls-concept:C0006491lld:lifeskim
pubmed-article:9725109lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9725109lifeskim:mentionsumls-concept:C1550147lld:lifeskim
pubmed-article:9725109lifeskim:mentionsumls-concept:C0678335lld:lifeskim
pubmed-article:9725109lifeskim:mentionsumls-concept:C2003874lld:lifeskim
pubmed-article:9725109pubmed:issue3lld:pubmed
pubmed-article:9725109pubmed:dateCreated1998-12-3lld:pubmed
pubmed-article:9725109pubmed:abstractTextThree groups of rats (N = 23) self-administered intravenous cocaine (0.4 mg/kg/infusion) during the initial 2 hr of daily 7-hr sessions. During the remaining 5 hr of these sessions, responding produced saline infusions. On test days, each rat was pretreated with an assigned dose of either butorphanol, morphine, amphetamine, or saline before the self-administration session followed by a priming injection of cocaine (3.2 mg/kg i.v.) or saline at the beginning of the 4th hr. Results showed that both amphetamine (0.5, 1.0, and 2.0 mg/kg) and morphine (0.3, 1.0, and 2.0 mg/kg) pretreatment dose-dependently reduced cocaine self-administration whereas only amphetamine affected (increased) reinstatement responding. Butorphanol pretreatment (8 mg/kg) suppressed cocaine self-administration and blocked the effect of the cocaine priming injections on pretreatment testing days. These findings indicate that (a) pretreatment drugs with similar stimulus properties potentiate reinstatement of responding and (b) pretreatment drugs can differentially affect maintenance and reinstatement of responding.lld:pubmed
pubmed-article:9725109pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9725109pubmed:languageenglld:pubmed
pubmed-article:9725109pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9725109pubmed:citationSubsetIMlld:pubmed
pubmed-article:9725109pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9725109pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9725109pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9725109pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9725109pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9725109pubmed:statusMEDLINElld:pubmed
pubmed-article:9725109pubmed:monthAuglld:pubmed
pubmed-article:9725109pubmed:issn1064-1297lld:pubmed
pubmed-article:9725109pubmed:authorpubmed-author:CarrollM EMElld:pubmed
pubmed-article:9725109pubmed:authorpubmed-author:LynchW JWJlld:pubmed
pubmed-article:9725109pubmed:authorpubmed-author:HeaserW AWAlld:pubmed
pubmed-article:9725109pubmed:issnTypePrintlld:pubmed
pubmed-article:9725109pubmed:volume6lld:pubmed
pubmed-article:9725109pubmed:ownerNLMlld:pubmed
pubmed-article:9725109pubmed:authorsCompleteYlld:pubmed
pubmed-article:9725109pubmed:pagination255-63lld:pubmed
pubmed-article:9725109pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9725109pubmed:meshHeadingpubmed-meshheading:9725109-...lld:pubmed
pubmed-article:9725109pubmed:meshHeadingpubmed-meshheading:9725109-...lld:pubmed
pubmed-article:9725109pubmed:meshHeadingpubmed-meshheading:9725109-...lld:pubmed
pubmed-article:9725109pubmed:meshHeadingpubmed-meshheading:9725109-...lld:pubmed
pubmed-article:9725109pubmed:meshHeadingpubmed-meshheading:9725109-...lld:pubmed
pubmed-article:9725109pubmed:meshHeadingpubmed-meshheading:9725109-...lld:pubmed
pubmed-article:9725109pubmed:meshHeadingpubmed-meshheading:9725109-...lld:pubmed
pubmed-article:9725109pubmed:meshHeadingpubmed-meshheading:9725109-...lld:pubmed
pubmed-article:9725109pubmed:meshHeadingpubmed-meshheading:9725109-...lld:pubmed
pubmed-article:9725109pubmed:meshHeadingpubmed-meshheading:9725109-...lld:pubmed
pubmed-article:9725109pubmed:meshHeadingpubmed-meshheading:9725109-...lld:pubmed
pubmed-article:9725109pubmed:meshHeadingpubmed-meshheading:9725109-...lld:pubmed
pubmed-article:9725109pubmed:year1998lld:pubmed
pubmed-article:9725109pubmed:articleTitleEffects of amphetamine, butorphanol, and morphine pretreatment on the maintenance and reinstatement of cocaine-reinforced responding.lld:pubmed
pubmed-article:9725109pubmed:affiliationDepartment of Psychiatry, University of Minnesota, Minneapolis 55455, USA. lynch020@maroon.tc.umn.edulld:pubmed
pubmed-article:9725109pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9725109pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9725109pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9725109lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9725109lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9725109lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9725109lld:pubmed